Indeed, in glioma cells from the C57/GL261 orthotopic glioma model, we found that repaglinide significantly reduced PD-L1 expression, which correlates with the increase of TIL and the increase of survival time of mice (Xiao et al., 2017). This evidence concerns the gene CD274 and central nervous system cancer.